arrow
S

Sang Hoon Chun

Catholic University of Korea
H指数:19
被引数:953

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19-09, CONPELAN Study

局部晚期鼻咽癌根治性化放疗后巩固性帕博利珠单抗的随机II期临床试验:KCSG HN19-09,CONPELAN研究

2026-05-010
OAAI
Predictive and Prognostic Value of p16 in Head and Neck Squamous Cell Carcinoma Patients Treated with Molecular Targeted Agents or Immune Checkpoint Inhibitors: Subgroup Analysis of the TRIUMPH Study

p16在经分子靶向药物或免疫检查点抑制剂治疗的头颈部鳞状细胞癌患者中的预测和预后价值:TRIUMPH研究的亚组分析

2026-02-010
PRE
The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

临床危险因素、CAR指数和免疫细胞组成变化对接受免疫治疗的非小细胞肺癌患者进展性疾病的影响

2021-01-0523
OAAI